Diabetes and Kidney Disease

This course will a comprehensive review of the management of diabetic kidney disease (DKD), including discussions of blood pressure control, new biomarkers and hypoglycemia agents on DKD development and progression.

Target Audience

Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Endocrinologists, Respiratory Therapists, Nurses, Nurse Practitioners and other interested healthcare professionals

Learning Objectives

• Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
• Explain the contribution of blood pressure control with different agents on DKD development and progression.
• Describe how new biomarkers can help to stratify patients.
• Summarize the contribution of different hypoglycemia agents on DKD development and progression.

Additional information
Bibliography: 
  • Williams, J. K. Y. (2017). Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes. Nursing Clinics, 52(4), 575-587.

Available Topics

Nephrology Online Series (Multiple Modules)

This online series includes timely content relevant to the treatment of nephrology patients. Please visit us often as we continue to build this online nephrology medicine library.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Course opens: 
03/01/2018
Course expires: 
02/28/2021

Alessia Fornoni, M.D., Ph.D.
Professor of Medicine
Chief, Katz Family Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami
Miami, Florida

Alessia Fornoni, M.D., Ph.D., indicated that she has relevant financial relationships and she will not include off-label or unapproved product usage in her presentation or discussion.
Grant/Research Support: Roche, Boehringer Ingelheim
Consultant: Variant Pharmaceutical, Ono, Pfeizer, Boehringer Ingelheim, AstraZeneca, Roche, Merck and Johnson and Johnson.
Stock Shareholder: Variant Pharmaceuticals

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
             
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Please login or register to take this course.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet.
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play.
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.